CCAUX
Price
$26.75
Change
-$0.00 (-0.00%)
Updated
Jun 12 closing price
Net Assets
305.61M
FCMAX
Price
$12.36
Change
-$0.00 (-0.00%)
Updated
Jun 12 closing price
Net Assets
1.87B
Interact to see
Advertisement

CCAUX vs FCMAX

Header iconCCAUX vs FCMAX Comparison
Open Charts CCAUX vs FCMAXBanner chart's image
CCAUX vs FCMAX Comparison Chart in %
View a ticker or compare two or three
VS
CCAUX vs. FCMAX commentary
Jun 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCAUX is a Hold and FCMAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FCMAX has more cash in the bank: 1.87B vs. CCAUX (306M). CCAUX pays higher dividends than FCMAX: CCAUX (3.78) vs FCMAX (2.70). CCAUX was incepted earlier than FCMAX: CCAUX (10 years) vs FCMAX (24 years). FCMAX (0.76) is less costly to investors than CCAUX (0.57). CCAUX is a more actively managed with annual turnover of: 20.00 vs. FCMAX (19.00). CCAUX (0) and FCMAX (0) have matching initial minimum investment requirements. CCAUX annual gain was more profitable for investors over the last year : 7.56 vs. FCMAX (6.56). FCMAX return over 5 years is better than : 2.99 vs. CCAUX (0.19).
CCAUXFCMAXCCAUX / FCMAX
Total Expense Ratio0.510.7667%
Annual Report Gross Expense Ratio0.570.7675%
Fund Existence10 years24 years-
Gain YTD1.9520.962203%
Front LoadN/A4%-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets306M1.87B16%
Annual Yield % from dividends3.782.70140%
Returns for 1 year7.566.56115%
Returns for 3 years14.0911.66121%
Returns for 5 years0.192.996%
Returns for 10 years14.9517.0088%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VSME1.690.58
+52.25%
VS Media Holdings Limited
PENN21.680.47
+2.22%
PENN Entertainment
NRIM25.800.28
+1.10%
Northrim BanCorp
BEN32.130.32
+1.01%
Franklin Resources
PTHS27.50-1.22
-4.25%
Pelthos Therapeutics Inc